-
Pharmacies Face 1st Trial Over Role in Opioid Crisis
A bellwether trial is set to start Monday in federal court in Cleveland to determine whether retail pharmacy chains are liable for costs related to the opioid crisis in two Ohio counties
-
Profits Drive High Drug Prices, House Investigation Finds
Enormous drug company profits are the primary driver of soaring prescription drug prices in America, according to a damning investigation that Democrats on the House Oversight Committee began releasing Wednesday. The first two reports in the investigation focus on Celgene and Bristol Myers Squibb’s Revlimid cancer treatment, which saw its price hiked 23 times since 2005, and Teva’s multiple sclerosis…
-
Oxford, AstraZeneca to Resume Coronavirus Vaccine Trial
Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.
-
Court Strikes Down Trump Rule That Drugmakers Disclose Price
In a major legal setback for President Donald Trump on a high-profile consumer issue, a federal appeals court has ruled that his administration lacks the legal authority to force drug companies to disclose prices in their TV ads
-
US to Set Up Plan Allowing Prescription Meds From Canada
The Trump administration said Wednesday it will create a way for Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of refusals by health authorities amid a public outcry over high prices for life-sustaining medications. The move is a step toward fulfilling a 2016 campaign promise by President Donald Trump, and it...
-
No Obligation to the Public, Opioid Distributor Tells Lawyer
An executive at one of the nation’s largest drug distribution companies said under questioning recently that the business has no obligation to the public when it comes to the amount of prescription opioid painkillers it ships. That’s one of the exchanges included in thousands of pages of court documents, including depositions and internal emails, made public this week in lawsuits...
-
UN Health Agency to Remove Controversial Opioid Guidelines
The World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the...
-
UN Health Agency to Remove Controversial Opioid Guidelines
The World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the...
-
Facebook Cracks Down on Vaccine Misinformation
Facebook announced on Thursday new policies to reduce the visibility of vaccine misinformation on its platform, including rejecting advertising and excluding groups and pages from search results that spread “vaccine hoaxes.” The announcement comes after weeks of criticism from public health advocates and lawmakers who have called for action to curtail inaccurate information about vaccines, which have led to a...
-
Some Turn to Medical Marijuana in Opioid Crisis Fight
While medical marijuana is legal in Massachusetts, most doctors aren’t recommending it to their patients and in many cases are instead prescribing highly addictive opioids. Some however, suggest a solution.
-
Some Turn to Medical Marijuana for Relief in Opioid Crisis
While medical marijuana is legal in Massachusetts, most doctors aren’t recommending it to their patients and, in many cases, are instead prescribing highly addictive opioids. Some, however, suggest a solution.
-
Skimping Can't Save Seniors From Higher Medical Costs: Gov't Report
Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general’s office says it found a 17 percent drop in the overall number of prescriptions for brand-name medications under...
-
Revolving Door of Despair: Drugs Land More Women Behind Bars
Tucked in a remote corner of Appalachia, the Campbell County Jail offers an agonizing glimpse into how the tidal wave of opioids and methamphetamines has ravaged America. Here and across the country, addiction is driving skyrocketing rates of incarcerated women, tearing apart families while squeezing communities that lack money, treatment programs and permanent solutions to close the revolving door. Women...
-
As States Consider Taxing Opioids, Drugmakers Push Back
Facing a rising death toll from drug overdoses, state lawmakers across the country are testing a strategy to boost treatment for opioid addicts: Force drug manufacturers and their distributors to pay for it. Bills introduced in at least 15 states would impose taxes or fees on prescription painkillers. Several of the measures have bipartisan support and would funnel millions of...
-
Opioids Haunt Users' Recovery: ‘It Never Really Leaves You'
Businessman Kyle Graves shot himself in the ankle so emergency room doctors would feed his opioid habit. Ex-trucker Jeff McCoy threatened to blow his brains out if his mother didn’t hand over his fentanyl patches. Bianca Knight resorted to street pills when her opioids ran out, envisioning her law career dreams crumble. These are three Americans who started using powerful...
-
Cancer Patients' Gray Hair Turned Dark in Trials for New Immune Drugs
Cancer patients’ gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads. Chemotherapy is notorious for making hair fall out, but the 14 patients involved were all being treated with new immunotherapy drugs that work differently and have different side effects. A Spanish study suggests that may include restoring hair pigment, at least...
-
Trump Picks Former FDA Official to Head Agency
President Donald Trump announced Friday that he has chosen a conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry to lead the powerful Food and Drug Administration. Dr. Scott Gottlieb would be tasked with Trump’s goal of cutting red tape at the FDA, which regulates everything from pharmaceuticals to seafood to electronic cigarettes. Trump has called the...